Background Our client, a leading player in the global pharmaceutical industry, faced a surplus asset challenge in its China operations. Following a reallocation of resources, the... read more →
[minti_headline type="h3" size="fontsize-xxxl" weight="fontweight-700"... read more →
[minti_headline type="h3" size="fontsize-xxxl" weight="fontweight-700"... read more →
[minti_headline type="h3" size="fontsize-xxxl"... read more →
A global biotech company wanted some visibility on their surplus assets. They were about to go through some huge changes; mergers and acquisition, some site closures. They really didn't understand... read more →
Challenge A Europe-based, multinational pharmaceutical and biologics company was in the process of reviewing the usage of a Scandinavian plant and related equipment. Originally opened in the mid-1990s,... read more →